Novocure (NVCR) Misses Q2 EPS by 11c

Novocure (NASDAQ: NVCR) reported Q2 EPS of ($0.48), $0.11 worse than the analyst estimate of ($0.37). Revenue for the quarter came in at $17.9 million versus the consensus estimate of $15.9 million.

For earnings history and earnings-related data on Novocure (NVCR) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Bernstein SocGen Reiterates Outperform Rating on Fervo Energy (FRVO)
• Goldman "broadly" raises estimates for LTL and truckload stocks